https://doi.org/10.4081/hmr.v3i1.522

First line therapy for peripheral T-cell lymphoma

Vol. 3 No. 1: 2006...2009: Now we know T-cell lymphomas better, Bologna, Italy, 16-18 March 2009
Published: June 11, 2009
Abstract Views: 170
PDF: 1244
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

D. Sibon
support@pagepress.org
T-cell non-Hodgkin's lymphomas (NHL) are rare in Europe and the United States, where they constitute about 10-15% of aggressive lymphomas. The prognostic significance of the immunophenotype has been explored in several studies and results have been reported concerning the outcome of PTCL compared to that of B-cell lymphomas (BCL). PTCL patients were found to have generally poorer prognoses than patients with BCL. However, PTCL represent a heterogeneous group of lymphomas and a wide variety of different histological subtypes have been recognized. The most common subtype is an heterogeneous group of PTCL not other specified (PTCL-NOS), followed by anaplastic large cell lymphoma (ALCL), angioimmunoblastic Tcell lymphoma (AITL). Some uncommon PTCL subtypes have been included in series and are not always easy to identify in reports.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Sibon, D. (2009). First line therapy for peripheral T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports), 3(1). https://doi.org/10.4081/hmr.v3i1.522
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).